Wei Qu

机构：China Jiliang University · ORCID：0009-0000-9662-750X

发表论文 104 篇 · 总被引 1677 次 · h-index 21

代表论文

• Heparin-binding protein as a biomarker of severe sepsis in the pediatric intensive care unit: A multicenter, prospective study (2022 · Clinica Chimica Acta · 被引 19)
• New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker? (2022 · Neoplasma · 被引 19)
• [99mTc]Tc-Galacto-RGD2 integrin αvβ3-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data (2021 · EJNMMI Research · 被引 10)
• From bench to bedside: Synthetic strategies and clinical application of PARP inhibitors (2025 · Bioorganic Chemistry · 被引 7)
• Triple-targeting nanosystems with synergistic effects on iron Trojan horse, fluoroquinolone antibiotics, and photodynamic therapy specifically kill intracellular MRSA (2025 · Theranostics · 被引 5)
• Use of Chromogranin A for Monitoring Patients With Pancreatic Neuroendocrine Neoplasms (2021 · Pancreas · 被引 5)